Hong-Xin Wang (Hongxin Wang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Pulmonary Hypertension

Top Venues

Journal of cellular and molecular medicine

Neural plasticity

Oxidative medicine and cellular longevity

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine 27 (5) (2023)
Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine (2023)
Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine 27 (5) (2023)
Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine 27 (5) (2023)
Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine 27 (5) (2023)
Yu Liu, Bai-Lin Tang, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway. Journal of cellular and molecular medicine 27 (5) (2023)
Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Haiyan Deng, Xiaoxue Tian, Hening Sun, Huan Liu, Meili Lu, Hong-Xin Wang
Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension. Journal of cellular and molecular medicine 26 (10) (2022)
Yan Meng, Shengxue Yu, Fang Zhao, Meili Lu, Yue Wang, Siqi Fan, Yuhong Su, Mei-Li Lu, Hong-Xin Wang
Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway. Neural plasticity 2022 (2022)
Yang Sun, Mei-Li Lu, Tairan Sun, Hong-Xin Wang
Astragaloside IV attenuates inflammatory response mediated by NLRP-3/calpain-1 is involved in the development of pulmonary hypertension. Journal of cellular and molecular medicine 25 (1) (2020)
Bin Leng, Cong Li, Yang Sun, Kun Zhao, Ling Zhang, Mei-Li Lu, Hong-Xin Wang
Protective Effect of Astragaloside IV on High Glucose-Induced Endothelial Dysfunction via Inhibition of P2X7R Dependent P38 MAPK Signaling Pathway. Oxidative medicine and cellular longevity 2020 (2020)
Bin Leng, Yingjie Zhang, Xinran Liu, Zhen Zhang, Yang Liu, Hong-Xin Wang, Mei-Li Lu
Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR. Mediators of inflammation 2019 (2019)